Skip to content
Back to Investors
H

Hummingbird

Venture Capital

Portfolio

4

companies

Investment by month

By category

  • AI/ML£223M
  • Robotics£69.8M
  • HealthTech£9.4M

By location

  • London£302M

Portfolio companies

A

Anima

Anima builds a universal operating system for clinical care.

Automata

Automata

Automata builds modular laboratory automation platforms for the life sciences sector.

BR

Basecamp Research

Basecamp Research uses artificial intelligence to explore beyond known biology and solve life science challenges.

O

Olix

Olix designs specialised hardware to accelerate artificial intelligence inference in data centres.


Recent investments

Series B
£45.9M

Singular led the Series B round, which will help fund data collection and foundational model development.

"We are pushing past AI’s limits in biological design by doubling down on solving the fundamental data gap that the entire biotech industry faces, Basecamp Research is using its technology to generate new and deeper insights, going beyond known biology and each day expand what we can offer to our partners in the biopharma ecosystem."
— Glen Gowers, co-founder and CEO
Series A
€11.0M

The Y Combinator alumnus has raised capital from Molten Ventures, Hummingbird, and Amino Collective to scale its clinical operating system.

"We’re excited to bring Inga of Molten on our journey. From day one, it was clear to us that she shared our vision of care enablement, a thesis Inga and Molten have had for years. I’m deeply grateful for the special crew we have at Anima. This is a passion project – we’re building what we wish we had as doctors and patients. No one is here just to do a job. We all serve a greater purpose – and that’s why ultimately we’ll continue to move mountains."
— Shun Pang, Co-founder and CEO
£33.1M

Dimension led the funding round, with participation from A.P. Moller Holding and several returning investors.

"The last two years have been hugely exciting at Automata as we’ve seen LINQ increase the scale of customer workflows as well as meaningfully increasing their ability to generate high quality data – accelerating their pace of discovery and experimentation."
— Mostafa ElSayed, CEO